Unable to obtain endometrial biopsies due to cervical stenosis.
Colon cancer: [**Location (un) **] B2 in [**2172**] status post resection followed  by chemotherapy and radiation.
EF 70% mild LVH, tr MT, tr TR, mild AI  10. h/o sz d/o  11. glaucoma PSH: C/S, colectomy x2, OB: C/S x1 Gyn: no abnl pap, no sti   Social History: divorced, lives alone.
previously worked as a clinical laboratory scientist and was exposed to benzine and "other chemicals", however denies any occupational or known inhalation exposure.
Physical Exam: Initial exam notable for nl vulva, atrophic vagina, cervix not well visualized limited  but normal bimanual and rectovaginal exam  Pertinent Results: [**2181-3-8**] 12:02PM BLOOD Hct-26.6* [**2181-3-10**] 08:00AM BLOOD WBC-5.9 RBC-3.52* Hgb-11.5* Hct-32.9* MCV-94 MCH-32.7* MCHC-35.0 RDW-13.4 Plt Ct-116* [**2181-3-12**] 05:25AM BLOOD WBC-3.4* RBC-3.43* Hgb-11.0* Hct-31.6* MCV-92 MCH-32.2* MCHC-34.8 RDW-13.5 Plt Ct-106*  [**2181-3-9**] 04:05AM BLOOD PT-12.4 PTT-21.1* INR(PT)-1.0  [**2181-3-8**] 12:02PM BLOOD Glucose-233* UreaN-21* Creat-1.6* Na-141 K-4.0 Cl-107 HCO3-24 AnGap-14 [**2181-3-10**] 08:00AM BLOOD Glucose-174* UreaN-26* Creat-2.6* Na-141 K-4.4 Cl-109* HCO3-19* AnGap-17 [**2181-3-10**] 08:00AM BLOOD Calcium-8.3* Phos-4.2 Mg-1.9 [**2181-3-12**] 05:25AM BLOOD Glucose-113* UreaN-28* Creat-2.1* Na-138 K-3.8 Cl-105 HCO3-24 AnGap-13 [**2181-3-12**] 05:25AM BLOOD Calcium-7.9* Phos-3.8 Mg-1.6  [**2181-3-13**] 05:40AM BLOOD UreaN-30* Creat-1.6*  Brief Hospital Course: The patient was admitted to the ICU following her surgery on [**2181-3-8**] for management of oliguric acute renal failure and blood sugar control.
Her surgery was difficult due to the effects of  prior radiation therapy.
She was given fluid challenge as well as 2 units of pRBC with no improvement in uop.
[**Name10 (NameIs) **] urine output gradually improved and she had brisk diuresis on post op day 2.
3) Type 1 Diabetes: Her blood sugars were followed closely in the perioperative period.
She was continued on a regular insulin sliding scale and NPH.
Her ACE inhibitor was held in the setting of acute renal failure.
She was continued on metoprolol which was increased to 100mg [**Hospital1 **].
Hydralazine was added for improved control in place of enalapril.
Medications on Admission: Keppra 500 mg po bid NPH 22 u q am HISS enalapril 20 mg po bid metoprolol 50 mg po bid  Discharge Medications: 1.
Oxycodone-Acetaminophen 5-325 mg Tablet Sig: 1-2 Tablets PO Q4-6H (every 4 to 6 hours) as needed.
Hydralazine HCl 10 mg Tablet Sig: One (1) Tablet PO every eight (8) hours.
Metoprolol Tartrate 50 mg Tablet Sig: Two (2) Tablet PO BID (2 times a day).
Cephalexin 250 mg Capsule Sig: One (1) Capsule PO Q6H (every 6 hours) for 7 days.
Enalapril Maleate 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
